ConductScience.org, home

Paper41329461

CRISPR/Cas9 Genome Editing in Oncology: Mechanisms, Therapeutic Platforms and Translational Challenges.

Nguyen AH and 1 other. Mol Biotechnol, 2026. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. CRISPR/Cas9 Genome Editing in Oncology: Mechanisms, Therapeutic Platforms and Translational Challenges. Papers, record 41329461. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41329461

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CRISPR/Cas9 Genome Editing in Oncology: Mechanisms, Therapeutic Platforms and Translational Challenges.
PubMed
Journal
Mol Biotechnol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
3.47, provisional
iCite
Revised in PubMed
2026-11-05
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nguyen AHAnh-Duy Hoanghttps://orcid.org/0009-0007-6546-4008
2Quang MTMinh Tronghttps://orcid.org/0009-0008-0703-1922

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CRISPR-Cas SystemsMajor topic
NeoplasmsMajor topic
Gene EditingMajor topic
Humans
Animals
Genetic Therapy
Translational Research, Biomedical

Source PubMed

Download CSV of topics

References207

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131745080Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors.Nat Commun2019https://conductscience.org/library/papers/31745080PubMed
234963897Ultrasound-Controlled CRISPR/Cas9 System Augments Sonodynamic Therapy of Hepatocellular Carcinoma.ACS Cent Sci2021https://conductscience.org/library/papers/34963897PubMed
330666307Engineering and Design of Chimeric Antigen Receptors.Mol Ther Methods Clin Dev2019https://conductscience.org/library/papers/30666307PubMed
436969176Experimental mouse models for translational human cancer research.Front Immunol2023https://conductscience.org/library/papers/36969176PubMed
538734692Enhancing genome editing in hPSCs through dual inhibition of DNA damage response and repair pathways.Nat Commun2024https://conductscience.org/library/papers/38734692PubMed
640983440The role and regulation of cell death in cancer.Prog Mol Biol Transl Sci2025https://conductscience.org/library/papers/40983440PubMed
728807568Function of Novel Anti-CD19 Chimeric Antigen Receptors with Human Variable Regions Is Affected by Hinge and Transmembrane Domains.Mol Ther2017https://conductscience.org/library/papers/28807568PubMed
829385370Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.N Engl J Med2018https://conductscience.org/library/papers/29385370PubMed
921941284A decade of exploring the cancer epigenome - biological and translational implications.Nat Rev Cancer2011https://conductscience.org/library/papers/21941284PubMed
1038260716Recent Advancements in Reducing the Off-Target Effect of CRISPR-Cas9 Genome Editing.Biologics2024https://conductscience.org/library/papers/38260716PubMed
1139349459CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells.Nat Commun2024https://conductscience.org/library/papers/39349459PubMed
1226771115The Emerging Hallmarks of Cancer Metabolism.Cell Metab2016https://conductscience.org/library/papers/26771115PubMed
1326735016High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.Nature2016https://conductscience.org/library/papers/26735016PubMed
1425730490Highly efficient Cas9-mediated transcriptional programming.Nat Methods2015https://conductscience.org/library/papers/25730490PubMed
1538467308Orthotopic and metastatic tumour models in preclinical cancer research.Pharmacol Ther2024https://conductscience.org/library/papers/38467308PubMed
1627096365Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.Nature2016https://conductscience.org/library/papers/27096365PubMed
1737429857Cell cycle arrest and p53 prevent ON-target megabase-scale rearrangements induced by CRISPR-Cas9.Nat Commun2023https://conductscience.org/library/papers/37429857PubMed
1835952360Systematic Comparison of Pancreatic Ductal Adenocarcinoma Models Identifies a Conserved Highly Plastic Basal Cell State.Cancer Res2022https://conductscience.org/library/papers/35952360PubMed
1936894722Sniper2L is a high-fidelity Cas9 variant with high activity.Nat Chem Biol2023https://conductscience.org/library/papers/36894722PubMed
2038572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed

See all 207 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42771321Electroporation for High-Efficiency Delivery of CRISPR to Hematopoietic Cells.Methods Mol Biol2027https://conductscience.org/library/papers/42771321PubMed
42649936Overcoming Therapy Resistance in Ovarian Cancer: From Molecular Mechanisms to Emerging Therapeutic Strategies.Cancers (Basel)2026https://conductscience.org/library/papers/42649936PubMed
42601370Design and transfection of CRISPR/Cas9 constructs for the myostatin gene in Labeo rohita muscle cells.Sci Rep2026https://conductscience.org/library/papers/42601370PubMed
42211656CRISPR-driven strategies to disrupt methicillin-resistant Staphylococcus aureus biofilms: a review.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42211656PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41329461

GET https://conductscience.org/api/papers/v1/41329461/references?page=2